Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

105.77 -3.61 (-3.30%)
Streaming Delayed Price Updated: 3:31 PM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
71 72 Next >
News headline image
Moderna, BioNTech Jump After CDC Green-Lights Updated Covid Boosters ↗
These new shots target the BA.4 and BA.5 subvariants of omicron. 
Via Investor's Business Daily
News headline image
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary ↗
 
Via Benzinga
News headline image
Europe Backs Approval Of Omicron-Adapted COVID-19 Vaccines ↗
Health Canada has approved Moderna Inc's (NASDAQ: 
Via Benzinga
News headline image
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union
From Pfizer Inc.
Via Business Wire
News headline image
Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash... ↗
Wall Street Journal 
Via Benzinga
News headline image
Why Novavax Shares Are Getting Hammered After Moderna, Pfizer And BioNTech News ↗
Novavax, Inc. (NASDAQ: NVAX) shares are trading lower by 6.76% to $32.84 Wednesday afternoon in possible reaction to competitor Moderna Inc (NASDAQ: MRNA) receiving FDA authorization for emergency use... 
Via Benzinga
News headline image
Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer, Moderna Nab FDA Authorization For Updated Covid Boosters ↗
Boosters are recommended two months out from the last shot. 
Via Investor's Business Daily
News headline image
Benzinga Before The Bell: Tesla Sues Louisiana Automobile Dealers Association, Will iPhone 14 Feature Satellite Connectivity?, Netflix Denies $7 To $9 Ad-Supported Plan And Other Top Financial Stories Tuesday, August 30 ↗
Reuters Taiwan’s China Airlines Orders 16 Boeing 787s 
Via Benzinga
News headline image
US Stock Futures Higher Ahead Of Economic Data, Fed Speakers ↗
Pre-open movers U.S. stock futures traded higher in early pre-market trade as investors digested comments from Federal Reserve Chairman Jerome Powell. Markets closed lower again on Monday, with the... 
Via Benzinga
News headline image
Pfizer-BioNTech, Moderna Set To Get FDA Nod For Omicron Booster Shots As Early As Wednesday: Report ↗
Booster shots for Omicron variants of the novel coronavirus could officially be made available in the U.S. just after Labor Day, Politico reported on Monday. 
Via Benzinga
News headline image
Recap Of Friday's Biotech Catalysts - End Of the Day Summary ↗
 
Via Benzinga
News headline image
Pfizer/BioNTech Complete European Submission For Omicron Subvariant Adapted Vaccine ↗
 
Via Benzinga
News headline image
Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent Vaccine
From Pfizer Inc.
Via Business Wire
News headline image
Moderna Claims Pfizer, BioNTech Stole Its Patented Tech In Covid Shot ↗
The lawsuit alleges Comirnaty violates Moderna's patents from 2010-16. 
Via Investor's Business Daily
News headline image
Moderna Entangles Pfizer/BioNTech In COVID-19 Vaccine Patent Lawsuits: All You Need To Know ↗
Moderna Inc (NASDAQ: MRNA) has  
Via Benzinga
News headline image
Pfizer And Moderna Are In A Race With Omicron; Will The Vaccine Stocks Be Too Late? ↗
The companies hope to launch updated boosters this fall. This is what experts think of their prospects. 
Via Investor's Business Daily
News headline image
AstraZeneca's CEO Says There Are No COVID Regrets, Looks For Oncology Acquisitions ↗
In a Reuters report, AstraZeneca Plc's (NASDAQ: 
Via Benzinga
News headline image
Moderna Asks FDA To Sign Off On Its Updated Covid Booster Shot ↗
Moderna put the finishing touches on its FDA filing Tuesday, trailing its rivals by a day. 
Via Investor's Business Daily
News headline image
Pfizer/BioNTech's COVID-19 Vaccine Updated Data Shows Around 76% Efficacy In Toddlers ↗
Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have  
Via Benzinga
News headline image
Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age
From Pfizer Inc.
Via Business Wire
News headline image
Recap Of Monday's Biotech Catalysts - End Of the Day Summary ↗
 
Via Benzinga
News headline image
Boosters Are Coming For Dangerous Omicron COVID-19 Variant. Here's Who May Be Rolling Them Out ↗
 
Via Benzinga
News headline image
Face Of US COVID-19 Response, Dr Anthony Fauci To Retire In December ↗
  
Via Benzinga
News headline image
Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine
From Pfizer Inc.
Via Business Wire
News headline image
Benzinga Before The Bell: Apple Employees Resist Calls For Return-To-Office, Tesla About To Hike FSD Prices Again, MGM China Injects $594M Into Macau Unit And Other Top Financial Stories Monday, August 22 ↗
Reuters Vodafone To Sell Hungarian Business For $1.8B: Report 
Via Benzinga
News headline image
Canada OKs Pfizer COVID-19 Booster For Kids Aged 5-11 Years ↗
 
Via Benzinga
News headline image
Covid Stocks Pfizer, Moderna, Novavax Face Their Next Challenge, And It's Worth Billions ↗
How they handle an upcoming shift in payments will be telling for their tailwind. 
Via Investor's Business Daily
News headline image
Biden Administration To Stop Purchasing COVID-19 Solutions By End Of 2022 ↗
 
Via Benzinga
News headline image
7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher ↗
These monkeypox stocks could be among the best choices to buy in August. Each can make great investments as government responses ramp up. 
Via InvestorPlace
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
71 72 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.